AstraZeneca and HUST launch Health Innovation Hub in Vietnam
Matthew Brady
The Health Innovation Hub aims to accelerate AI-driven healthcare solutions and expand equitable access to advanced medical technologies across Vietnam.
News
Ping An selected for national pilot on workplace health management
Under the initiative, Ping An will deploy its QiKang corporate health management framework, which emphasises a shift from claims-based healthcare towards preventive care.
KFSHRC develops novel technique to treat inner ear disorders using ultra-micro 3D printing technology
KFSHRC
First clinical use of the technique treated a patient with two years of severe vertigo and imbalance from a superior semicircular canal defect.
Ping An Good Doctor expands home-based senior care services to over 100 cities in China
Ping An Good Doctor is also developing a “travel-and-stay” senior care model that is supported by AI tools and an integrated online-to-offline service network.
Bupa CareConnect partners with InterSystems to advance digital healthcare and enhance patient care
The rollout is intended to give Bupa CareConnect members more streamlined access to care, with a consistent experience across appointment booking, consultations and follow-up services.
Ant Group updates AQ health app with AI companion, health Q&A, and integrated services
Ant Group's AI health companion service AQ, now known as Ant A-Fu in China, has grown to 15 million monthly active users since launching in June 2025.
Saudi team uses 3D-printed guides to preserve patient’s leg in complex surgery
3D-printed guides enabled precise, limb-saving surgery on a tumour near the upper femur and hip.
Longevity startup Bien-Etre to introduce biological age testing platform in the UAE
Bien-Etre’s platform provides consumers with access to epigenetic biomarker tests and data-driven supplement recommendations.
Singapore-MIT Alliance launches world-first wearable ultrasound research project
WITEC focuses on the development of wearable ultrasound imaging technology capable of up to 48 hours of intermittent cardiovascular monitoring.